Symbols / UTMD Stock $67.87 -2.53% Utah Medical Products, Inc.

Healthcare • Medical Instruments & Supplies • United States • NMS
UTMD (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; BioPharm HP-PRT; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health center in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Stock Fundamentals
Scroll to Statements
Market Cap 217.43M Enterprise Value 130.70M Income 11.29M Sales 38.52M Book/sh 37.43 Cash/sh 26.93
Dividend Yield 1.83% Payout 35.20% Employees 140 IPO — P/E 19.50 Forward P/E —
PEG 4.25 P/S 5.64 P/B 1.81 P/C — EV/EBITDA 8.32 EV/Sales 3.39
Quick Ratio 34.36 Current Ratio 37.62 Debt/Eq 0.24 LT Debt/Eq — EPS (ttm) 3.48 EPS next Y —
EPS Growth -6.40% Revenue Growth -1.20% Earnings 2026-04-23 ROA 6.51% ROE 9.54% ROIC —
Gross Margin 57.12% Oper. Margin 31.17% Profit Margin 29.30% Shs Outstand 3.19M Shs Float 2.76M Short Float 5.04%
Short Ratio 8.37 Short Interest — 52W High 71.81 52W Low 51.26 Beta 0.35 Avg Volume 15.35K
Volume 20.83K Target Price — Recom None Prev Close $69.63 Price $67.87 Change -2.53%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$67.87
Latest analyst target
3. DCF / Fair value
$62.91
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$67.87
Low
—
High
—
Mean
—
News
RSS: Latest UTMD news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-09-04 KOOPMAN BRIAN L. Officer — 50 $62.75 $3,138
2025-08-25 RICHINS PAUL O Director — 100 $60.34 $6,034
2024-07-18 KOOPMAN BRIAN L. Officer — 50 $71.61 $3,580
2024-05-17 RICHINS PAUL O Director — 225 $69.72 $15,687
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
38.52
-5.83%
40.90
-18.56%
50.22
-3.93%
52.28
Operating Revenue
38.52
-5.83%
40.90
-18.56%
50.22
-3.93%
52.28
Cost Of Revenue
16.52
-1.44%
16.76
-16.97%
20.19
+0.50%
20.09
Reconciled Cost Of Revenue
16.52
-1.44%
16.76
-16.97%
20.19
+0.50%
20.09
Gross Profit
22.00
-8.87%
24.14
-19.63%
30.04
-6.70%
32.20
Operating Expense
10.60
+0.47%
10.55
-20.45%
13.26
+6.89%
12.41
Research And Development
0.67
-17.84%
0.81
+45.18%
0.56
+13.59%
0.49
Selling General And Administration
9.93
+2.00%
9.74
-23.34%
12.70
+6.61%
11.91
Selling And Marketing Expense
2.05
+7.89%
1.90
+12.82%
1.69
+11.81%
1.51
General And Administrative Expense
7.88
+0.57%
7.83
-28.88%
11.02
+5.86%
10.41
Other Gand A
7.88
+0.57%
7.83
-28.88%
11.02
+5.86%
10.41
Total Expenses
27.12
-0.70%
27.31
-18.35%
33.45
+2.94%
32.49
Operating Income
11.40
-16.12%
13.59
-18.97%
16.78
-15.22%
19.79
Total Operating Income As Reported
11.40
-16.12%
13.59
-18.97%
16.78
-15.22%
19.79
EBITDA
14.41
-12.35%
16.44
-28.97%
23.14
-13.87%
26.87
Normalized EBITDA
11.60
-11.25%
13.07
-34.99%
20.11
-23.28%
26.21
Reconciled Depreciation
3.01
+5.69%
2.85
-55.31%
6.37
-10.08%
7.08
EBIT
11.40
-16.12%
13.59
-18.97%
16.78
-15.22%
19.79
Total Unusual Items
2.81
-16.60%
3.37
+10.90%
3.04
+359.30%
0.66
Total Unusual Items Excluding Goodwill
2.81
-16.60%
3.37
+10.90%
3.04
+359.30%
0.66
Net Income
11.29
-18.65%
13.87
-16.60%
16.64
+0.98%
16.47
Pretax Income
14.11
-16.02%
16.80
-16.36%
20.09
-2.76%
20.66
Other Income Expense
2.71
-15.59%
3.21
-3.14%
3.31
+281.13%
0.87
Other Non Operating Income Expenses
-0.10
+37.11%
-0.16
-157.61%
0.28
+32.69%
0.21
Gain On Sale Of Security
2.81
-16.60%
3.37
+10.90%
3.04
+359.30%
0.66
Tax Provision
2.82
-3.55%
2.93
-15.23%
3.45
-17.49%
4.19
Tax Rate For Calcs
0.00
+14.85%
0.00
+1.32%
0.00
-15.11%
0.00
Tax Effect Of Unusual Items
0.56
-4.22%
0.59
+12.36%
0.52
+289.89%
0.13
Net Income Including Noncontrolling Interests
11.29
-18.65%
13.87
-16.60%
16.64
+0.98%
16.47
Net Income From Continuing Operation Net Minority Interest
11.29
-18.65%
13.87
-16.60%
16.64
+0.98%
16.47
Net Income From Continuing And Discontinued Operation
11.29
-18.65%
13.87
-16.60%
16.64
+0.98%
16.47
Net Income Continuous Operations
11.29
-18.65%
13.87
-16.60%
16.64
+0.98%
16.47
Normalized Income
9.04
-18.51%
11.09
-21.44%
14.12
-11.44%
15.95
Net Income Common Stockholders
11.29
-18.65%
13.87
-16.60%
16.64
+0.98%
16.47
Diluted EPS
—
3.96
-13.40%
4.57
+1.15%
4.52
Basic EPS
—
4.16
-9.22%
4.58
-19.52%
5.69
Basic Average Shares
—
3.34
-8.12%
3.63
+0.06%
3.63
Diluted Average Shares
—
3.50
-3.68%
3.64
-0.16%
3.64
Diluted NI Availto Com Stockholders
11.29
-18.65%
13.87
-16.60%
16.64
+0.98%
16.47
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
122.54
+0.00%
122.54
-9.54%
135.46
+9.35%
123.87
Current Assets
97.74
+1.47%
96.33
-9.35%
106.27
+18.18%
89.92
Cash Cash Equivalents And Short Term Investments
85.76
+3.35%
82.98
-10.65%
92.87
+23.74%
75.05
Cash And Cash Equivalents
85.76
+3.35%
82.98
-10.65%
92.87
+23.74%
75.05
Cash Financial
85.76
+3.35%
82.98
-10.65%
92.87
+23.74%
75.05
Receivables
3.52
-13.97%
4.09
+20.77%
3.39
-38.79%
5.54
Accounts Receivable
4.04
-4.81%
4.24
+21.53%
3.49
-37.02%
5.54
Receivables Adjustments Allowances
-0.52
-260.14%
-0.14
+5.30%
-0.15
+17.03%
-0.18
Accrued Interest Receivable
0.00
+200.00%
-0.00
-103.77%
0.05
+3.92%
0.05
Inventory
7.93
-9.95%
8.81
-8.04%
9.58
+8.71%
8.81
Raw Materials
5.08
-7.29%
5.49
-14.22%
6.39
+11.69%
5.72
Work In Process
1.63
+15.06%
1.41
-5.92%
1.50
+25.98%
1.19
Finished Goods
1.22
-36.07%
1.91
+13.53%
1.69
-11.13%
1.90
Prepaid Assets
—
—
—
0.52
Other Current Assets
0.53
+18.08%
0.45
+4.43%
0.43
-16.70%
0.52
Total Non Current Assets
24.80
-5.37%
26.21
-10.21%
29.19
-14.04%
33.95
Net PPE
9.91
+1.49%
9.76
-7.47%
10.55
+3.20%
10.22
Gross PPE
35.25
+4.62%
33.69
-1.70%
34.27
+3.33%
33.17
Accumulated Depreciation
-25.34
-5.91%
-23.93
-0.86%
-23.72
-3.39%
-22.94
Properties
0.00
0.00
0.00
0.00
Land And Improvements
1.70
+5.80%
1.60
-2.08%
1.64
+2.82%
1.59
Buildings And Improvements
14.38
+6.25%
13.54
-2.65%
13.91
+2.25%
13.60
Machinery Furniture Equipment
19.05
+2.85%
18.53
+7.00%
17.32
+1.45%
17.07
Construction In Progress
0.11
+478.95%
0.02
-98.66%
1.41
+55.96%
0.91
Other Properties
—
—
—
—
Goodwill And Other Intangible Assets
14.89
-9.44%
16.45
-11.77%
18.64
-21.46%
23.73
Goodwill
14.05
+3.48%
13.58
-0.82%
13.69
+2.53%
13.35
Other Intangible Assets
0.84
-70.68%
2.87
-42.07%
4.95
-52.34%
10.38
Total Liabilities Net Minority Interest
3.27
-35.94%
5.11
-28.47%
7.14
-25.73%
9.62
Current Liabilities
2.60
-30.85%
3.76
-20.23%
4.71
-20.97%
5.96
Payables And Accrued Expenses
2.53
-30.61%
3.65
-18.12%
4.45
-22.64%
5.76
Payables
0.00
-99.63%
0.54
-50.46%
1.10
-29.52%
1.55
Accounts Payable
0.91
+30.89%
0.70
-9.49%
0.77
-36.86%
1.22
Current Accrued Expenses
2.53
-18.53%
3.10
-7.57%
3.36
-20.09%
4.20
Total Tax Payable
-0.91
-494.12%
-0.15
-146.79%
0.33
-2.97%
0.34
Income Tax Payable
-0.91
-494.12%
-0.15
-146.79%
0.33
-2.97%
0.34
Total Non Current Liabilities Net Minority Interest
0.68
-50.07%
1.35
-44.39%
2.44
-33.47%
3.66
Long Term Debt And Capital Lease Obligation
0.23
-20.21%
0.28
-4.41%
0.29
-13.49%
0.34
Long Term Capital Lease Obligation
0.23
-20.21%
0.28
-4.41%
0.29
-13.49%
0.34
Tradeand Other Payables Non Current
—
0.00
-100.00%
0.70
-44.43%
1.26
Non Current Deferred Liabilities
0.45
-57.93%
1.07
-25.66%
1.44
-30.10%
2.06
Non Current Deferred Taxes Liabilities
0.45
-57.93%
1.07
-25.66%
1.44
-30.10%
2.06
Stockholders Equity
119.27
+1.57%
117.43
-8.48%
128.31
+12.31%
114.25
Common Stock Equity
119.27
+1.57%
117.43
-8.48%
128.31
+12.31%
114.25
Capital Stock
0.03
-3.03%
0.03
-8.33%
0.04
+0.00%
0.04
Common Stock
0.03
-3.03%
0.03
-8.33%
0.04
+0.00%
0.04
Share Issued
3.19
-4.47%
3.34
-8.12%
3.63
+0.06%
3.63
Ordinary Shares Number
3.19
-4.47%
3.34
-8.12%
3.63
+0.06%
3.63
Additional Paid In Capital
0.00
0.00
-100.00%
0.59
+136.65%
0.25
Retained Earnings
128.65
-0.50%
129.30
-6.53%
138.34
+9.79%
126.01
Gains Losses Not Affecting Retained Earnings
-9.42
+20.93%
-11.91
-11.73%
-10.66
+11.47%
-12.04
Other Equity Adjustments
-9.42
+20.93%
-11.91
-11.73%
-10.66
+11.47%
-12.04
Total Equity Gross Minority Interest
119.27
+1.57%
117.43
-8.48%
128.31
+12.31%
114.25
Total Capitalization
119.27
+1.57%
117.43
-8.48%
128.31
+12.31%
114.25
Working Capital
95.14
+2.78%
92.57
-8.85%
101.56
+20.96%
83.96
Invested Capital
119.27
+1.57%
117.43
-8.48%
128.31
+12.31%
114.25
Total Debt
0.23
-20.21%
0.28
-4.41%
0.29
-13.49%
0.34
Capital Lease Obligations
0.23
-20.21%
0.28
-4.41%
0.29
-13.49%
0.34
Net Tangible Assets
104.38
+3.36%
100.98
-7.93%
109.67
+21.16%
90.52
Tangible Book Value
104.38
+3.36%
100.98
-7.93%
109.67
+21.16%
90.52
Current Provisions
0.07
-38.74%
0.11
-56.81%
0.26
+25.98%
0.20
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
14.69
-0.94%
14.83
-33.44%
22.28
+5.36%
21.15
Cash Flow From Continuing Operating Activities
14.69
-0.94%
14.83
-33.44%
22.28
+5.36%
21.15
Net Income From Continuing Operations
11.29
-18.65%
13.87
-16.60%
16.64
+0.98%
16.47
Depreciation Amortization Depletion
3.01
+5.69%
2.85
-55.31%
6.37
-10.08%
7.08
Depreciation
0.88
+12.93%
0.78
+15.53%
0.68
+1.65%
0.67
Amortization Cash Flow
2.13
+2.95%
2.06
-63.72%
5.69
-11.30%
6.42
Depreciation And Amortization
3.01
+5.69%
2.85
-55.31%
6.37
-10.08%
7.08
Amortization Of Intangibles
2.13
+2.95%
2.06
-63.72%
5.69
-11.30%
6.42
Stock Based Compensation
0.37
+45.70%
0.26
+13.78%
0.23
+22.95%
0.18
Provisionand Write Offof Assets
0.37
+9275.00%
-0.00
+87.88%
-0.03
-210.00%
0.03
Deferred Tax
-0.66
-94.97%
-0.34
+50.37%
-0.68
-72.41%
-0.40
Deferred Income Tax
-0.66
-94.97%
-0.34
+50.37%
-0.68
-72.41%
-0.40
Change In Working Capital
0.32
+117.58%
-1.80
-673.82%
-0.23
+89.53%
-2.23
Change In Receivables
0.33
+142.64%
-0.78
-134.41%
2.27
+532.38%
-0.53
Changes In Account Receivables
0.34
+140.48%
-0.83
-136.78%
2.27
+544.23%
-0.51
Change In Inventory
1.20
+103.58%
0.59
+187.61%
-0.67
+71.53%
-2.35
Change In Prepaid Assets
-0.05
-68.75%
-0.03
-171.11%
0.04
+170.31%
-0.06
Change In Payables And Accrued Expense
-1.16
+26.63%
-1.58
+16.03%
-1.88
-362.29%
0.72
Change In Accrued Expense
-1.37
+9.04%
-1.50
-5.77%
-1.42
-664.29%
0.25
Change In Payable
0.21
+389.04%
-0.07
+83.99%
-0.46
-198.28%
0.46
Change In Account Payable
0.21
+389.04%
-0.07
+83.99%
-0.46
-198.28%
0.46
Investing Cash Flow
-0.37
-78.37%
-0.21
+67.45%
-0.64
+21.88%
-0.82
Cash Flow From Continuing Investing Activities
-0.37
-78.37%
-0.21
+67.45%
-0.64
+21.88%
-0.82
Net PPE Purchase And Sale
0.00
-100.00%
0.03
0.00
0.00
Purchase Of PPE
—
—
—
-0.81
Sale Of PPE
0.00
-100.00%
0.03
0.00
0.00
Capital Expenditure
-0.37
-57.87%
-0.23
+63.22%
-0.64
+21.88%
-0.82
Capital Expenditure Reported
-0.37
-57.87%
-0.23
+63.22%
-0.64
+21.88%
-0.82
Net Intangibles Purchase And Sale
—
—
—
—
Purchase Of Intangibles
—
—
—
—
Financing Cash Flow
-12.34
+48.24%
-23.84
-472.34%
-4.17
+24.05%
-5.48
Cash Flow From Continuing Financing Activities
-12.34
+48.24%
-23.84
-472.34%
-4.17
+24.05%
-5.48
Net Common Stock Issuance
-8.36
+58.16%
-19.97
0.00
+100.00%
-2.50
Common Stock Payments
-8.36
+58.16%
-19.97
0.00
+100.00%
-2.50
Common Stock Dividend Paid
-3.98
+6.50%
-4.26
+0.51%
-4.28
-35.38%
-3.16
Cash Dividends Paid
-3.98
+6.50%
-4.26
+0.51%
-4.28
-35.38%
-3.16
Repurchase Of Capital Stock
-8.36
+58.16%
-19.97
0.00
+100.00%
-2.50
Proceeds From Stock Option Exercised
0.00
-100.00%
0.39
+233.33%
0.12
-32.76%
0.17
Changes In Cash
1.98
+121.52%
-9.21
-152.73%
17.48
+17.73%
14.85
Effect Of Exchange Rate Changes
0.80
+217.73%
-0.68
-299.71%
0.34
+144.20%
-0.77
Beginning Cash Position
82.98
-10.65%
92.87
+23.74%
75.05
+23.09%
60.97
End Cash Position
85.76
+3.35%
82.98
-10.65%
92.87
+23.74%
75.05
Free Cash Flow
14.32
-1.88%
14.60
-32.56%
21.64
+6.46%
20.33
Interest Paid Supplemental Data
0.00
0.00
0.00
0.00
Income Tax Paid Supplemental Data
4.00
-13.69%
4.64
-3.92%
4.83
-2.88%
4.97
Change In Income Tax Payable
—
—
—
—
Change In Tax Payable
—
—
—
—
Excess Tax Benefit From Stock Based Compensation
—
—
0.01
+100.00%
0.01
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category